Report Overview
It refers to the highly conservative, double stranded RNA induced, highly specific degradation of homologous mRNA in the evolutionary process
The global RNAi Drugs market size was estimated at USD 69200 million in 2023 and is projected to reach USD 396345.81 million by 2032, exhibiting a CAGR of 21.40% during the forecast period.
North America RNAi Drugs market size was estimated at USD 25253.23 million in 2023, at a CAGR of 18.34% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global RNAi Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global RNAi Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the RNAi Drugs market in any manner.
Global RNAi Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alnylam
Novo Nordisk
Eli Lilly
Alexion
Novartis
Roche
Arrowhead Pharmaceuticals Inc.
CureVac AG
Dicerna Pharmaceuticals Inc.
Gradalis Inc.
Ionis Pharmaceuticals Inc
Merck & Co. Inc.
Moderna Inc.
SBI ALApharma
Silence Therapeutics Plc
Sirnaomics Inc.
Market Segmentation (by Type)
siRNA
shRNA
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the RNAi Drugs Market
Overview of the regional outlook of the RNAi Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the RNAi Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of RNAi Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of RNAi Drugs
1.2 Key Market Segments
1.2.1 RNAi Drugs Segment by Type
1.2.2 RNAi Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RNAi Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global RNAi Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global RNAi Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RNAi Drugs Market Competitive Landscape
3.1 Global RNAi Drugs Sales by Manufacturers (2019-2025)
3.2 Global RNAi Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 RNAi Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global RNAi Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers RNAi Drugs Sales Sites, Area Served, Product Type
3.6 RNAi Drugs Market Competitive Situation and Trends
3.6.1 RNAi Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest RNAi Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RNAi Drugs Industry Chain Analysis
4.1 RNAi Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of RNAi Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RNAi Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global RNAi Drugs Sales Market Share by Type (2019-2025)
6.3 Global RNAi Drugs Market Size Market Share by Type (2019-2025)
6.4 Global RNAi Drugs Price by Type (2019-2025)
7 RNAi Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global RNAi Drugs Market Sales by Application (2019-2025)
7.3 Global RNAi Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global RNAi Drugs Sales Growth Rate by Application (2019-2025)
8 RNAi Drugs Market Consumption by Region
8.1 Global RNAi Drugs Sales by Region
8.1.1 Global RNAi Drugs Sales by Region
8.1.2 Global RNAi Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America RNAi Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe RNAi Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific RNAi Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America RNAi Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa RNAi Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 RNAi Drugs Market Production by Region
9.1 Global Production of RNAi Drugs by Region (2019-2025)
9.2 Global RNAi Drugs Revenue Market Share by Region (2019-2025)
9.3 Global RNAi Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America RNAi Drugs Production
9.4.1 North America RNAi Drugs Production Growth Rate (2019-2025)
9.4.2 North America RNAi Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe RNAi Drugs Production
9.5.1 Europe RNAi Drugs Production Growth Rate (2019-2025)
9.5.2 Europe RNAi Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan RNAi Drugs Production (2019-2025)
9.6.1 Japan RNAi Drugs Production Growth Rate (2019-2025)
9.6.2 Japan RNAi Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China RNAi Drugs Production (2019-2025)
9.7.1 China RNAi Drugs Production Growth Rate (2019-2025)
9.7.2 China RNAi Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Alnylam
10.1.1 Alnylam RNAi Drugs Basic Information
10.1.2 Alnylam RNAi Drugs Product Overview
10.1.3 Alnylam RNAi Drugs Product Market Performance
10.1.4 Alnylam Business Overview
10.1.5 Alnylam RNAi Drugs SWOT Analysis
10.1.6 Alnylam Recent Developments
10.2 Novo Nordisk
10.2.1 Novo Nordisk RNAi Drugs Basic Information
10.2.2 Novo Nordisk RNAi Drugs Product Overview
10.2.3 Novo Nordisk RNAi Drugs Product Market Performance
10.2.4 Novo Nordisk Business Overview
10.2.5 Novo Nordisk RNAi Drugs SWOT Analysis
10.2.6 Novo Nordisk Recent Developments
10.3 Eli Lilly
10.3.1 Eli Lilly RNAi Drugs Basic Information
10.3.2 Eli Lilly RNAi Drugs Product Overview
10.3.3 Eli Lilly RNAi Drugs Product Market Performance
10.3.4 Eli Lilly RNAi Drugs SWOT Analysis
10.3.5 Eli Lilly Business Overview
10.3.6 Eli Lilly Recent Developments
10.4 Alexion
10.4.1 Alexion RNAi Drugs Basic Information
10.4.2 Alexion RNAi Drugs Product Overview
10.4.3 Alexion RNAi Drugs Product Market Performance
10.4.4 Alexion Business Overview
10.4.5 Alexion Recent Developments
10.5 Novartis
10.5.1 Novartis RNAi Drugs Basic Information
10.5.2 Novartis RNAi Drugs Product Overview
10.5.3 Novartis RNAi Drugs Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Roche
10.6.1 Roche RNAi Drugs Basic Information
10.6.2 Roche RNAi Drugs Product Overview
10.6.3 Roche RNAi Drugs Product Market Performance
10.6.4 Roche Business Overview
10.6.5 Roche Recent Developments
10.7 Arrowhead Pharmaceuticals Inc.
10.7.1 Arrowhead Pharmaceuticals Inc. RNAi Drugs Basic Information
10.7.2 Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Overview
10.7.3 Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Market Performance
10.7.4 Arrowhead Pharmaceuticals Inc. Business Overview
10.7.5 Arrowhead Pharmaceuticals Inc. Recent Developments
10.8 CureVac AG
10.8.1 CureVac AG RNAi Drugs Basic Information
10.8.2 CureVac AG RNAi Drugs Product Overview
10.8.3 CureVac AG RNAi Drugs Product Market Performance
10.8.4 CureVac AG Business Overview
10.8.5 CureVac AG Recent Developments
10.9 Dicerna Pharmaceuticals Inc.
10.9.1 Dicerna Pharmaceuticals Inc. RNAi Drugs Basic Information
10.9.2 Dicerna Pharmaceuticals Inc. RNAi Drugs Product Overview
10.9.3 Dicerna Pharmaceuticals Inc. RNAi Drugs Product Market Performance
10.9.4 Dicerna Pharmaceuticals Inc. Business Overview
10.9.5 Dicerna Pharmaceuticals Inc. Recent Developments
10.10 Gradalis Inc.
10.10.1 Gradalis Inc. RNAi Drugs Basic Information
10.10.2 Gradalis Inc. RNAi Drugs Product Overview
10.10.3 Gradalis Inc. RNAi Drugs Product Market Performance
10.10.4 Gradalis Inc. Business Overview
10.10.5 Gradalis Inc. Recent Developments
10.11 Ionis Pharmaceuticals Inc
10.11.1 Ionis Pharmaceuticals Inc RNAi Drugs Basic Information
10.11.2 Ionis Pharmaceuticals Inc RNAi Drugs Product Overview
10.11.3 Ionis Pharmaceuticals Inc RNAi Drugs Product Market Performance
10.11.4 Ionis Pharmaceuticals Inc Business Overview
10.11.5 Ionis Pharmaceuticals Inc Recent Developments
10.12 Merck and Co. Inc.
10.12.1 Merck and Co. Inc. RNAi Drugs Basic Information
10.12.2 Merck and Co. Inc. RNAi Drugs Product Overview
10.12.3 Merck and Co. Inc. RNAi Drugs Product Market Performance
10.12.4 Merck and Co. Inc. Business Overview
10.12.5 Merck and Co. Inc. Recent Developments
10.13 Moderna Inc.
10.13.1 Moderna Inc. RNAi Drugs Basic Information
10.13.2 Moderna Inc. RNAi Drugs Product Overview
10.13.3 Moderna Inc. RNAi Drugs Product Market Performance
10.13.4 Moderna Inc. Business Overview
10.13.5 Moderna Inc. Recent Developments
10.14 SBI ALApharma
10.14.1 SBI ALApharma RNAi Drugs Basic Information
10.14.2 SBI ALApharma RNAi Drugs Product Overview
10.14.3 SBI ALApharma RNAi Drugs Product Market Performance
10.14.4 SBI ALApharma Business Overview
10.14.5 SBI ALApharma Recent Developments
10.15 Silence Therapeutics Plc
10.15.1 Silence Therapeutics Plc RNAi Drugs Basic Information
10.15.2 Silence Therapeutics Plc RNAi Drugs Product Overview
10.15.3 Silence Therapeutics Plc RNAi Drugs Product Market Performance
10.15.4 Silence Therapeutics Plc Business Overview
10.15.5 Silence Therapeutics Plc Recent Developments
10.16 Sirnaomics Inc.
10.16.1 Sirnaomics Inc. RNAi Drugs Basic Information
10.16.2 Sirnaomics Inc. RNAi Drugs Product Overview
10.16.3 Sirnaomics Inc. RNAi Drugs Product Market Performance
10.16.4 Sirnaomics Inc. Business Overview
10.16.5 Sirnaomics Inc. Recent Developments
11 RNAi Drugs Market Forecast by Region
11.1 Global RNAi Drugs Market Size Forecast
11.2 Global RNAi Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe RNAi Drugs Market Size Forecast by Country
11.2.3 Asia Pacific RNAi Drugs Market Size Forecast by Region
11.2.4 South America RNAi Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of RNAi Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global RNAi Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of RNAi Drugs by Type (2025-2032)
12.1.2 Global RNAi Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of RNAi Drugs by Type (2025-2032)
12.2 Global RNAi Drugs Market Forecast by Application (2025-2032)
12.2.1 Global RNAi Drugs Sales (K MT) Forecast by Application
12.2.2 Global RNAi Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. RNAi Drugs Market Size Comparison by Region (M USD)
Table 5. Global RNAi Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global RNAi Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global RNAi Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global RNAi Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Drugs as of 2022)
Table 10. Global Market RNAi Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers RNAi Drugs Sales Sites and Area Served
Table 12. Manufacturers RNAi Drugs Product Type
Table 13. Global RNAi Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of RNAi Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. RNAi Drugs Market Challenges
Table 22. Global RNAi Drugs Sales by Type (K MT)
Table 23. Global RNAi Drugs Market Size by Type (M USD)
Table 24. Global RNAi Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global RNAi Drugs Sales Market Share by Type (2019-2025)
Table 26. Global RNAi Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global RNAi Drugs Market Size Share by Type (2019-2025)
Table 28. Global RNAi Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global RNAi Drugs Sales (K MT) by Application
Table 30. Global RNAi Drugs Market Size by Application
Table 31. Global RNAi Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global RNAi Drugs Sales Market Share by Application (2019-2025)
Table 33. Global RNAi Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global RNAi Drugs Market Share by Application (2019-2025)
Table 35. Global RNAi Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global RNAi Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global RNAi Drugs Sales Market Share by Region (2019-2025)
Table 38. North America RNAi Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe RNAi Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific RNAi Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America RNAi Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa RNAi Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global RNAi Drugs Production (K MT) by Region (2019-2025)
Table 44. Global RNAi Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global RNAi Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global RNAi Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America RNAi Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe RNAi Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan RNAi Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China RNAi Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Alnylam RNAi Drugs Basic Information
Table 52. Alnylam RNAi Drugs Product Overview
Table 53. Alnylam RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Alnylam Business Overview
Table 55. Alnylam RNAi Drugs SWOT Analysis
Table 56. Alnylam Recent Developments
Table 57. Novo Nordisk RNAi Drugs Basic Information
Table 58. Novo Nordisk RNAi Drugs Product Overview
Table 59. Novo Nordisk RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Novo Nordisk Business Overview
Table 61. Novo Nordisk RNAi Drugs SWOT Analysis
Table 62. Novo Nordisk Recent Developments
Table 63. Eli Lilly RNAi Drugs Basic Information
Table 64. Eli Lilly RNAi Drugs Product Overview
Table 65. Eli Lilly RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Eli Lilly RNAi Drugs SWOT Analysis
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Recent Developments
Table 69. Alexion RNAi Drugs Basic Information
Table 70. Alexion RNAi Drugs Product Overview
Table 71. Alexion RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Alexion Business Overview
Table 73. Alexion Recent Developments
Table 74. Novartis RNAi Drugs Basic Information
Table 75. Novartis RNAi Drugs Product Overview
Table 76. Novartis RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Novartis Business Overview
Table 78. Novartis Recent Developments
Table 79. Roche RNAi Drugs Basic Information
Table 80. Roche RNAi Drugs Product Overview
Table 81. Roche RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Roche Business Overview
Table 83. Roche Recent Developments
Table 84. Arrowhead Pharmaceuticals Inc. RNAi Drugs Basic Information
Table 85. Arrowhead Pharmaceuticals Inc. RNAi Drugs Product Overview
Table 86. Arrowhead Pharmaceuticals Inc. RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Arrowhead Pharmaceuticals Inc. Business Overview
Table 88. Arrowhead Pharmaceuticals Inc. Recent Developments
Table 89. CureVac AG RNAi Drugs Basic Information
Table 90. CureVac AG RNAi Drugs Product Overview
Table 91. CureVac AG RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. CureVac AG Business Overview
Table 93. CureVac AG Recent Developments
Table 94. Dicerna Pharmaceuticals Inc. RNAi Drugs Basic Information
Table 95. Dicerna Pharmaceuticals Inc. RNAi Drugs Product Overview
Table 96. Dicerna Pharmaceuticals Inc. RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Dicerna Pharmaceuticals Inc. Business Overview
Table 98. Dicerna Pharmaceuticals Inc. Recent Developments
Table 99. Gradalis Inc. RNAi Drugs Basic Information
Table 100. Gradalis Inc. RNAi Drugs Product Overview
Table 101. Gradalis Inc. RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Gradalis Inc. Business Overview
Table 103. Gradalis Inc. Recent Developments
Table 104. Ionis Pharmaceuticals Inc RNAi Drugs Basic Information
Table 105. Ionis Pharmaceuticals Inc RNAi Drugs Product Overview
Table 106. Ionis Pharmaceuticals Inc RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Ionis Pharmaceuticals Inc Business Overview
Table 108. Ionis Pharmaceuticals Inc Recent Developments
Table 109. Merck and Co. Inc. RNAi Drugs Basic Information
Table 110. Merck and Co. Inc. RNAi Drugs Product Overview
Table 111. Merck and Co. Inc. RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Merck and Co. Inc. Business Overview
Table 113. Merck and Co. Inc. Recent Developments
Table 114. Moderna Inc. RNAi Drugs Basic Information
Table 115. Moderna Inc. RNAi Drugs Product Overview
Table 116. Moderna Inc. RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Moderna Inc. Business Overview
Table 118. Moderna Inc. Recent Developments
Table 119. SBI ALApharma RNAi Drugs Basic Information
Table 120. SBI ALApharma RNAi Drugs Product Overview
Table 121. SBI ALApharma RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. SBI ALApharma Business Overview
Table 123. SBI ALApharma Recent Developments
Table 124. Silence Therapeutics Plc RNAi Drugs Basic Information
Table 125. Silence Therapeutics Plc RNAi Drugs Product Overview
Table 126. Silence Therapeutics Plc RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Silence Therapeutics Plc Business Overview
Table 128. Silence Therapeutics Plc Recent Developments
Table 129. Sirnaomics Inc. RNAi Drugs Basic Information
Table 130. Sirnaomics Inc. RNAi Drugs Product Overview
Table 131. Sirnaomics Inc. RNAi Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Sirnaomics Inc. Business Overview
Table 133. Sirnaomics Inc. Recent Developments
Table 134. Global RNAi Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 135. Global RNAi Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 136. North America RNAi Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 137. North America RNAi Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 138. Europe RNAi Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 139. Europe RNAi Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 140. Asia Pacific RNAi Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 141. Asia Pacific RNAi Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 142. South America RNAi Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 143. South America RNAi Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 144. Middle East and Africa RNAi Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 145. Middle East and Africa RNAi Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 146. Global RNAi Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 147. Global RNAi Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 148. Global RNAi Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 149. Global RNAi Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 150. Global RNAi Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of RNAi Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global RNAi Drugs Market Size (M USD), 2019-2032
Figure 5. Global RNAi Drugs Market Size (M USD) (2019-2032)
Figure 6. Global RNAi Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. RNAi Drugs Market Size by Country (M USD)
Figure 11. RNAi Drugs Sales Share by Manufacturers in 2023
Figure 12. Global RNAi Drugs Revenue Share by Manufacturers in 2023
Figure 13. RNAi Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market RNAi Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by RNAi Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global RNAi Drugs Market Share by Type
Figure 18. Sales Market Share of RNAi Drugs by Type (2019-2025)
Figure 19. Sales Market Share of RNAi Drugs by Type in 2023
Figure 20. Market Size Share of RNAi Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of RNAi Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global RNAi Drugs Market Share by Application
Figure 24. Global RNAi Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global RNAi Drugs Sales Market Share by Application in 2023
Figure 26. Global RNAi Drugs Market Share by Application (2019-2025)
Figure 27. Global RNAi Drugs Market Share by Application in 2023
Figure 28. Global RNAi Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global RNAi Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America RNAi Drugs Sales Market Share by Country in 2023
Figure 32. U.S. RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada RNAi Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico RNAi Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe RNAi Drugs Sales Market Share by Country in 2023
Figure 37. Germany RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific RNAi Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific RNAi Drugs Sales Market Share by Region in 2023
Figure 44. China RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America RNAi Drugs Sales and Growth Rate (K MT)
Figure 50. South America RNAi Drugs Sales Market Share by Country in 2023
Figure 51. Brazil RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa RNAi Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa RNAi Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa RNAi Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global RNAi Drugs Production Market Share by Region (2019-2025)
Figure 62. North America RNAi Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe RNAi Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan RNAi Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China RNAi Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global RNAi Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global RNAi Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global RNAi Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global RNAi Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global RNAi Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global RNAi Drugs Market Share Forecast by Application (2025-2032)
